Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today
Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today
Cardiol Therapeutics Inc (NASDAQ:CRDL) shares are trading lower by 18.4% to $1.60 Wednesday morning after the company announced a $13.5 million public offering of 8,437,500 common shares priced at $1.60 per unit.
Cardiol Therapeutics Inc（納斯達克:CRDL）股價週三早盤下跌18.4%，跌至1.60美元，因公司宣佈以1.60美元每股的價格發行了8,437,500股普通股，募資1350萬美元。
What Else: Cardiol Therapeutics says the gross proceeds will be approximately $13.5 million before underwriting discounts, commissions and other related expenses.
其他：Cardiol Therapeutics稱，募資總額將約爲1350萬美元，未計承銷折扣、佣金和其他相關費用。
The company plans to use the net proceeds from the offering to advance the clinical development of its lead drug candidate, CardiolRx, which is being investigated for the treatment of recurrent pericarditis, a cardiovascular condition. Additionally, the funds will support general administrative expenses, working capital and other corporate purposes.
該公司計劃利用此次發行的淨收益推進其主力藥物候選品CardiolRx的臨床開發，該藥物正在研究用於治療複發性心包炎，一種心血管疾病。此外，這些資金將支持一般行政費用、營運資本和其他公司用途。
Canaccord Genuity is serving as the sole bookrunner for the offering, overseeing the distribution of the shares.
Canaccord Genuity將作爲本次發行的唯一包銷商，監督股票的分銷。
Read Also: Google Cries Foul As DOJ Moves To Break Up Search Giant, Calls Recommendations 'Radical' As Antitrust Ruling Aims To Limit Its Search Market Monopoly
閱讀更多：谷歌對DOJ分拆搜索巨頭提出異議，稱推薦內容「極端」，反壟斷裁決旨在限制其搜索市場壟斷
Should I Sell My CRDL Stock?
我應該賣出我的CRDL股票嗎？
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
賣出或持有股票很大程度上取決於投資者的策略和風險承受能力。短期交易者可能會出售表現優異的股票以鎖定資本收益，而長期投資者可能會在期待股價進一步增長的動盪中保持持有。
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
同樣，願意將損失最小化的交易者可能會出售下跌一定百分比的股票，而長期投資者則可能會將其視爲以折扣價買入更多股票的機會。
Shares of Cardiol Therapeutics have gained 68.09% year to date. This compares to the average annual return of -16.86%, meaning the stock has outperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity.
Cardiol Therapeutics股票今年迄今漲幅達68.09%。相比平均年回報率-16.86%，說明該股票表現優於歷史平均水平。投資者可以比較股票的走勢與歷史表現，來判斷這是否屬於正常波動或潛在交易機會。
For analysis tools, charting data and access to exclusive stock news, check out Benzinga PRO. Try it for free.
欲獲取分析工具、圖表數據和獨家股票新聞，請登錄Benzinga PRO。現在免費試用。
CRDL has a 52-week high of $3.12 and a 52-week low of $0.66.
CRDL的52周最高價爲3.12美元，52周最低價爲0.66美元。
譯文內容由第三人軟體翻譯。
